CN103275987A - Aqp5基因突变体及其应用 - Google Patents
Aqp5基因突变体及其应用 Download PDFInfo
- Publication number
- CN103275987A CN103275987A CN2013102420949A CN201310242094A CN103275987A CN 103275987 A CN103275987 A CN 103275987A CN 2013102420949 A CN2013102420949 A CN 2013102420949A CN 201310242094 A CN201310242094 A CN 201310242094A CN 103275987 A CN103275987 A CN 103275987A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- sample
- aqp5
- nucleotide sequence
- plantaris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101150011139 AQP5 gene Proteins 0.000 title claims abstract description 41
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 97
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 96
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 96
- 239000012472 biological sample Substances 0.000 claims abstract description 83
- 108090000976 Aquaporin 5 Proteins 0.000 claims abstract description 57
- 102000004392 Aquaporin 5 Human genes 0.000 claims abstract description 56
- 238000000034 method Methods 0.000 claims abstract description 39
- 238000012216 screening Methods 0.000 claims abstract description 36
- 229920001184 polypeptide Polymers 0.000 claims abstract description 17
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 17
- 239000000523 sample Substances 0.000 claims description 85
- 206010033554 Palmoplantar keratoderma Diseases 0.000 claims description 80
- 201000008743 palmoplantar keratosis Diseases 0.000 claims description 80
- 101000975474 Homo sapiens Keratin, type I cytoskeletal 10 Proteins 0.000 claims description 79
- 102100023970 Keratin, type I cytoskeletal 10 Human genes 0.000 claims description 79
- 239000002773 nucleotide Substances 0.000 claims description 52
- 125000003729 nucleotide group Chemical group 0.000 claims description 51
- 238000012163 sequencing technique Methods 0.000 claims description 39
- 230000008859 change Effects 0.000 claims description 37
- 206010064571 Gene mutation Diseases 0.000 claims description 17
- 239000000284 extract Substances 0.000 claims description 14
- 238000012408 PCR amplification Methods 0.000 claims description 13
- 239000002299 complementary DNA Substances 0.000 claims description 12
- 238000012360 testing method Methods 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 239000013614 RNA sample Substances 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 238000010276 construction Methods 0.000 claims description 8
- 238000010839 reverse transcription Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 238000002123 RNA extraction Methods 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 241001269238 Data Species 0.000 claims description 4
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims description 4
- 239000002853 nucleic acid probe Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 108020004999 messenger RNA Proteins 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000035772 mutation Effects 0.000 abstract description 10
- 102220008162 rs387907163 Human genes 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 33
- 108020004414 DNA Proteins 0.000 description 23
- 108090000623 proteins and genes Proteins 0.000 description 18
- 238000001514 detection method Methods 0.000 description 12
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 102000003567 TRPV4 Human genes 0.000 description 10
- 101150098315 TRPV4 gene Proteins 0.000 description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 102000010637 Aquaporins Human genes 0.000 description 4
- 108010063290 Aquaporins Proteins 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 210000000106 sweat gland Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000000815 hypotonic solution Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000007854 ligation-mediated PCR Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- 208000021386 Sjogren Syndrome Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000021018 autosomal dominant inheritance Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000869 mutational effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000032895 transmembrane transport Effects 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IVYQPSHHYIAUFO-VXKWHMMOSA-N GSK1016790A Chemical compound N([C@@H](CO)C(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)C=1SC2=CC=CC=C2C=1)CC(C)C)S(=O)(=O)C1=CC=C(Cl)C=C1Cl IVYQPSHHYIAUFO-VXKWHMMOSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000012097 Lipofectamine 2000 Substances 0.000 description 1
- 206010062049 Lymphocytic infiltration Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- 108091006263 SLC4A8 Proteins 0.000 description 1
- 102000011040 TRPV Cation Channels Human genes 0.000 description 1
- 108010062740 TRPV Cation Channels Proteins 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 210000001142 back Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000012254 genetic linkage analysis Methods 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000012402 patch clamp technique Methods 0.000 description 1
- 238000002205 phenol-chloroform extraction Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000003370 receptor cell Anatomy 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002887 superconductor Substances 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000003146 transient transfection Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310242094.9A CN103275987B (zh) | 2013-06-17 | 2013-06-17 | Aqp5基因突变体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310242094.9A CN103275987B (zh) | 2013-06-17 | 2013-06-17 | Aqp5基因突变体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103275987A true CN103275987A (zh) | 2013-09-04 |
CN103275987B CN103275987B (zh) | 2015-03-18 |
Family
ID=49058606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310242094.9A Active CN103275987B (zh) | 2013-06-17 | 2013-06-17 | Aqp5基因突变体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103275987B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104561015A (zh) * | 2013-10-25 | 2015-04-29 | 深圳华大基因科技有限公司 | Myl4基因突变体及其应用 |
CN106701531A (zh) * | 2016-12-21 | 2017-05-24 | 山东艾克韦生物技术有限公司 | 应用于第二代高通量测序的全自动dna文库制备装置 |
WO2018190612A1 (ko) * | 2017-04-12 | 2018-10-18 | 서울대학교산학협력단 | 아쿠아포린 5에 대한 자가항체를 특이적으로 인식하는 에피토프 펩타이드 및 그 용도 |
CN110577953A (zh) * | 2018-06-11 | 2019-12-17 | 深圳华大生命科学研究院 | 基因突变体及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005117897A2 (en) * | 2004-06-03 | 2005-12-15 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Hepoxilins and modulators of ichthyin for treatment skin disorders |
WO2007051836A2 (en) * | 2005-11-04 | 2007-05-10 | Centre National De Genotypage | Compositions for treating dermatological and neurological disorders |
-
2013
- 2013-06-17 CN CN201310242094.9A patent/CN103275987B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005117897A2 (en) * | 2004-06-03 | 2005-12-15 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Hepoxilins and modulators of ichthyin for treatment skin disorders |
WO2005117897A3 (en) * | 2004-06-03 | 2006-04-13 | Herche Medicale Inserm Inst Na | Hepoxilins and modulators of ichthyin for treatment skin disorders |
WO2007051836A2 (en) * | 2005-11-04 | 2007-05-10 | Centre National De Genotypage | Compositions for treating dermatological and neurological disorders |
WO2007051836A3 (en) * | 2005-11-04 | 2007-07-26 | Ct Nat De Genotypage | Compositions for treating dermatological and neurological disorders |
Non-Patent Citations (2)
Title |
---|
Ö GÜNDÜZ, KÇ ÖZSARAÇ, ME ERCIN: "Aquagenic Palmar Wrinkling Induced by Combined Use of Salazopyrin and Indomethacin", 《CASE REPORTS IN DERMATOLOGY》 * |
STRAUSBERG,R.L.,等: "Homo sapiens aquaporin 5, mRNA (cDNA clone MGC:33163 IMAGE:5269384), complete cds", 《GENBANK: BC032946.1》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104561015A (zh) * | 2013-10-25 | 2015-04-29 | 深圳华大基因科技有限公司 | Myl4基因突变体及其应用 |
CN104561015B (zh) * | 2013-10-25 | 2017-12-19 | 深圳华大基因股份有限公司 | Myl4基因突变体及其应用 |
CN106701531A (zh) * | 2016-12-21 | 2017-05-24 | 山东艾克韦生物技术有限公司 | 应用于第二代高通量测序的全自动dna文库制备装置 |
CN106701531B (zh) * | 2016-12-21 | 2019-02-01 | 山东艾克韦生物技术有限公司 | 应用于第二代高通量测序的全自动dna文库制备装置的测序方法 |
WO2018190612A1 (ko) * | 2017-04-12 | 2018-10-18 | 서울대학교산학협력단 | 아쿠아포린 5에 대한 자가항체를 특이적으로 인식하는 에피토프 펩타이드 및 그 용도 |
CN110577953A (zh) * | 2018-06-11 | 2019-12-17 | 深圳华大生命科学研究院 | 基因突变体及其应用 |
CN110577953B (zh) * | 2018-06-11 | 2024-02-20 | 深圳华大生命科学研究院 | 基因突变体及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103275987B (zh) | 2015-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104120132B (zh) | Fbn1基因突变体及其应用 | |
CN103275987B (zh) | Aqp5基因突变体及其应用 | |
CN106282195A (zh) | 基因突变体及其应用 | |
CN103374575B (zh) | Cyp4v2基因突变体及其应用 | |
CN103571847A (zh) | Foxc1基因突变体及其应用 | |
CN108893532A (zh) | 一种用于sma遗传病筛查的基因检测试剂盒及检测方法 | |
CN103911380A (zh) | Epas1基因突变体及其应用 | |
CN103834673A (zh) | Ext1基因突变体及其应用 | |
CN103374574B (zh) | Cyp4v2基因突变体及其应用 | |
CN104178487A (zh) | Atm基因突变体及其应用 | |
CN105838720B (zh) | Ptprq基因突变体及其应用 | |
CN104073499B (zh) | Tmc1基因突变体及其应用 | |
CN103849623A (zh) | Abcb6基因突变体及其应用 | |
CN104099338A (zh) | Myo15a基因突变体及其应用 | |
CN104164424A (zh) | Cc2d2a基因突变体及其应用 | |
CN105821062B (zh) | Amsh基因突变体及其应用 | |
CN103290031B (zh) | Card9基因突变体及其应用 | |
Pshennikova et al. | Analysis of GJB6 (Сx30) and GJB3 (Сx31) genes in deaf patients with monoallelic mutations in GJB2 (Сx26) gene in the Sakha Republic (Yakutia) | |
CN104178489B (zh) | Aagab基因突变体及其应用 | |
CN103509801A (zh) | 骨骼肌氯离子通道基因突变体及其应用 | |
CN103627710A (zh) | Spg11基因突变体及其应用 | |
CN105802974B (zh) | Bcs1l基因突变体及其应用 | |
CN105779463B (zh) | Vps13b基因突变体及其应用 | |
CN103571846B (zh) | Atp6v1b2基因突变体及其应用 | |
CN103993016B (zh) | Hif2a基因突变体及其检测与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN BGI CORPORATION Free format text: FORMER OWNER: BGI-SHENZHEN CO., LTD. Effective date: 20150729 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150729 Address after: Yantian District of Shenzhen City, Guangdong province 518083 Hongan street No. 21 China Comprehensive Park 7 Building 7 layer -14 layer Patentee after: BGI SHENZHEN CO LTD Address before: North Road No. 146, building 11F-3 Industrial Zone in Yantian District of Shenzhen city of Guangdong Province in 518083 Patentee before: BGI-Shenzhen Co., Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130904 Assignee: Tianjin Huada medical laboratory Co., Ltd. Assignor: BGI SHENZHEN CO LTD Contract record no.: 2015110000047 Denomination of invention: AQP5 gene mutant and application thereof Granted publication date: 20150318 License type: Exclusive License Record date: 20151124 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160414 Address after: 300308, Tianjin free trade zone (Airport Economic Zone) ring River Road, 80, airport business park, 201-1 East Building, room 3 Patentee after: Tianjin Huada medical laboratory Co., Ltd. Address before: Yantian District of Shenzhen City, Guangdong province 518083 Hongan street No. 21 China Comprehensive Park 7 Building 7 layer -14 layer Patentee before: BGI SHENZHEN CO LTD |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210425 Address after: 051430 building 4, Zhitong Yaogu, 197 Taihang South Street, high tech Zone, Shijiazhuang City, Hebei Province Patentee after: Shijiazhuang Huada medical laboratory Co.,Ltd. Patentee after: TIANJIN BGI MEDICAL LABORATORY Co.,Ltd. Address before: 300308, Tianjin free trade zone (Airport Economic Zone) ring River Road, 80, airport business park, 201-1 East Building, room 3 Patentee before: TIANJIN BGI MEDICAL LABORATORY Co.,Ltd. |